TSH Biopharm Corporation Limited (8432.TWO)

TWD 47.8

(0.63%)

Operating Income Summary of TSH Biopharm Corporation Limited

  • TSH Biopharm Corporation Limited's latest annual operating income in 2023 was 63.63 Million TWD , down -11.93% from previous year.
  • TSH Biopharm Corporation Limited's latest quarterly operating income in 2024 Q1 was 45.52 Million TWD , up 180.42% from previous quarter.
  • TSH Biopharm Corporation Limited reported an annual operating income of 84.97 Million TWD in 2022, up 38.11% from previous year.
  • TSH Biopharm Corporation Limited reported an annual operating income of 61.52 Million TWD in 2021, down -20.25% from previous year.
  • TSH Biopharm Corporation Limited reported a quarterly operating income of 26.64 Million TWD for 2024 Q2, down -47.56% from previous quarter.
  • TSH Biopharm Corporation Limited reported a quarterly operating income of 16.23 Million TWD for 2023 Q4, down -24.9% from previous quarter.

Annual Operating Income Chart of TSH Biopharm Corporation Limited (2023 - 2019)

Historical Annual Operating Income of TSH Biopharm Corporation Limited (2023 - 2019)

Year Operating Income Operating Income Growth
2023 63.63 Million TWD -11.93%
2022 84.97 Million TWD 38.11%
2021 61.52 Million TWD -20.25%
2020 77.15 Million TWD 37.29%
2019 56.19 Million TWD 0.0%

Peer Operating Income Comparison of TSH Biopharm Corporation Limited

Name Operating Income Operating Income Difference
Allied Biotech Corporation 88.71 Million TWD 28.275%
GeneFerm Biotechnology Co., Ltd. 153.56 Million TWD 58.565%
Easywell Biomedicals, Inc. -162.73 Million TWD 139.1%
TTY Biopharm Company Limited 1.37 Billion TWD 95.364%
Synmosa Biopharma Corporation 614.74 Million TWD 89.649%
Orient EuroPharma Co., Ltd. 84.55 Million TWD 24.746%
Center Laboratories, Inc. -79.26 Million TWD 180.275%
Tien Liang BioTech Co., Ltd. 20.43 Million TWD -211.362%
Orient Pharma Co., Ltd. 27.75 Million TWD -129.273%
InnoPharmax Inc. -64.83 Million TWD 198.135%
Johnson Chemical Pharmaceutical Works Co., Ltd. 105.57 Million TWD 39.728%
Excelsior Biopharma Inc. -81.12 Million TWD 178.432%
DV Biomed Co., Ltd. 173.54 Million TWD 63.336%
Foresee Pharmaceuticals Co., Ltd. -1 Billion TWD 106.315%
Handa Pharmaceuticals, Inc. 695.79 Million TWD 90.855%
UniPharma Co., Ltd. -27.3 Million TWD 333.034%
Anxo Pharmaceutical Co., Ltd. 53.15 Million TWD -19.711%
Alar Pharmaceuticals Inc. 385.52 Million TWD 83.495%
Winston Medical Supply Co., Ltd. 196.1 Million TWD 67.552%
Mercury Biopharmaceutical Corporation -45.69 Million TWD 239.265%
Bioray Biotech Co., Ltd -19.33 Million TWD 429.16%